About
Emefcy is a wastewater treatment company developing and commercializing energy-efficient and cost-effective wastewater treatment and reuse products. The company has developed two technologies, MABR and EBR, which address limitations in municipal and industrial plants. The Emefcy Membrane Aerated Biofilm Reactor (MABR) is a modular, decentralized wastewater treatment process that requires just 10% of the energy used by conventional technologies. This technology is based on spiral-wound respiring membranes that provide oxygen to the process and support the growth of a nitrifying biofilm. Through an integrated process of simultaneous nitrification and denitrification, the MABR produces high-quality effluent with less operational input. The modular product design enables distributed treatment and gradual expansion possibilities over time. MABR is suitable for wastewater treatment and reuse in small municipalities, hotels, resorts, casinos, campgrounds, mining camps, commercial centers, and golf courses. Emefcys Electrogenic Bio Reactor (EBR) treats industrial wastewater while simultaneously generating electricity from the process to be fed to the grid. EBR is an energy-positive wastewater treatment technology with a lower sludge-handling cost because very little sludge is produced. Like SABRE, EBR is based on a modular design, enabling gradual implementation and easy expansion. As of July 2017, Emefcy is merged with RWL Water, forming Fluence Corporation.
Funding history · 6 rounds · $13.3M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Emefcy's primary business?
- Emefcy is a wastewater treatment company that develops and commercializes energy-efficient and cost-effective wastewater treatment and reuse products.
- What are Emefcy's two main technologies?
- Emefcy has developed two technologies: the Membrane Aerated Biofilm Reactor (MABR) and the Electrogenic Bio Reactor (EBR).
- What is the status of Emefcy as of July 2017?
- As of July 2017, Emefcy merged with RWL Water to form Fluence Corporation, and is currently listed as inactive.
- When was Emefcy founded and where is it headquartered?
- Emefcy was founded in November 2007 and is headquartered in Tel Aviv-Yafo, Israel.
- What was Emefcy's total funding raised in USD?
- Emefcy raised a total of $13,289,290 USD across multiple funding rounds.
- When did Emefcy complete its Series D funding round?
- Emefcy completed its Series D funding round in December 2012, raising $6,000,000 USD.
- When did Emefcy begin trading on the ASX?
- Emefcy began trading on the ASX in December 2015 through a reverse merger.
- Did Emefcy receive any grants?
- Yes, Emefcy received a grant of $89,290 USD from the IIA in June 2014.
- What was a significant operational development for Emefcy in January 2017?
- In January 2017, Emefcy opened a sewage treatment plant in the Virgin Islands.